title: Incontinence during treatment with gabapentin.
authors.affiliation: Department of Neurological Sciences, Rush-Presbyterian-St. Luke's Medical Center, Chicago, IL 60612, USA.
authors.forename: A
authors.initials: A
authors.lastname: Gil-Nagel
authors.forename: S
authors.initials: S
authors.lastname: Gapany
authors.forename: K
authors.initials: K
authors.lastname: Blesi
authors.forename: N
authors.initials: N
authors.lastname: Villanueva
authors.forename: D
authors.initials: D
authors.lastname: Bergen
mesh_terms: D000085:Acetates / Q000009:adverse effects* / Q000627:therapeutic use; D000328:Adult; D000588:Amines; D000927:Anticonvulsants / Q000009:adverse effects* / Q000627:therapeutic use; D002648:Child; D003509:Cyclohexanecarboxylic Acids; D004827:Epilepsy / Q000188:drug therapy; D005242:Fecal Incontinence / Q000139:chemically induced*; D005260:Female; D000077206:Gabapentin; D006801:Humans; D008297:Male; D014549:Urinary Incontinence / Q000139:chemically induced*; D005680:gamma-Aminobutyric Acid
chemical_list: D000085:Acetates; D000588:Amines; D000927:Anticonvulsants; D003509:Cyclohexanecarboxylic Acids; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin